1. Association between the Expression Levels of MicroRNA-101, -103, and -29a with Autotaxin and Lysophosphatidic Acid Receptor 2 Expression in Gastric Cancer Patients
    Sara Tutunchi et al, 2022, Journal of Oncology CrossRef
  2. Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
    Geofrey Mahiki Mranda et al, 2022, Frontiers in Oncology CrossRef

  3. Hypoxia-Induced Placenta-Specific microRNA (miR-512-3p) Promotes Hepatocellular Carcinoma Progression by Targeting Large Tumor Suppressor Kinase 2


    Bohan Zhang et al, 2020, OncoTargets and Therapy CrossRef
  4. YAP facilitates melanoma migration through regulation of actin‐related protein 2/3 complex subunit 5 (ARPC5)
    Jason W. Lui et al, 2022, Pigment Cell & Melanoma Research CrossRef
  5. The deadly cross-talk between Hippo pathway and epithelial–mesenchymal transition (EMT) in cancer
    Ioanna Akrida et al, 2022, Molecular Biology Reports CrossRef
  6. Identifying LATS2 as a prognostic biomarker relevant to immune infiltrates in human esophageal squamous cell carcinoma
    Minqi Zhu et al, 2022, Frontiers in Genetics CrossRef
  7. Role of Hippo signaling pathway in occurrence, development, and treatment of primary hepatocellular carcinoma
    Hui-Xian Tang et al, 2022, World Chinese Journal of Digestology CrossRef
  8. A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer
    Feifan Wang et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
  9. Conservation of Epithelial-to-Mesenchymal Transition Process in Neural Crest Cells and Metastatic Cancer
    April Zhang et al, 2021, Cells Tissues Organs CrossRef
  10. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence
    Ping Yan et al, 2021, BMC Cancer CrossRef
  11. Emerging role of MicroRNA-Based theranostics in Hepatocellular Carcinoma
    Abdulhakim Umar Toro et al, 2023, Molecular Biology Reports CrossRef
  12. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
    Zhenqiang Sun et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
  13. The circSNX14 functions as a tumor suppressor via the miR-562/ LATS2 pathway in hepatocellular carcinoma cells
    Yan Wu et al, 2023, Journal of Molecular Histology CrossRef
  14. RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial–Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma
    Lu Zhang et al, 2022, Journal of Hepatocellular Carcinoma CrossRef